ISAREVE Trademark

Trademark Overview

On Monday, June 3, 2024, a trademark application was filed for ISAREVE with the United States Patent and Trademark Office. The USPTO has given the ISAREVE trademark a serial number of 79399887. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 4, 2025. This trademark is owned by DAIICHI SANKYO COMPANY, LIMITED. The ISAREVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, pseudoxanthoma, systemic lupus erythematosus, cardiovascular diseases, kidney diseases, Netherton syndrome.
isareve

General Information

Serial Number79399887
Word MarkISAREVE
Filing DateMonday, June 3, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 4, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, pseudoxanthoma, systemic lupus erythematosus, cardiovascular diseases, kidney diseases, Netherton syndrome.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 18, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Thursday, July 18, 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 11, 2024SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Wednesday, July 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 22, 2024ASSIGNED TO EXAMINER
Wednesday, July 24, 2024APPLICATION FILING RECEIPT MAILED
Monday, September 2, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 2, 2024REFUSAL PROCESSED BY MPU
Friday, August 30, 2024NON-FINAL ACTION WRITTEN
Saturday, August 31, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 30, 2024REFUSAL PROCESSED BY IB
Monday, January 27, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 27, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 27, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 27, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 27, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 3, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 27, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, February 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 3, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 6, 2025ASSIGNED TO EXAMINER
Monday, February 10, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2025PUBLISHED FOR OPPOSITION

Related Keywords

isareve diseases erythematosus lupus cardiovascular kidney syndrome netherton systemic leukemia treatment